X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4498) 4498
Book Review (879) 879
Publication (236) 236
Magazine Article (54) 54
Book Chapter (33) 33
Book / eBook (32) 32
Conference Proceeding (5) 5
Trade Publication Article (5) 5
Government Document (4) 4
Web Resource (4) 4
Dissertation (2) 2
Paper (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3942) 3942
humans (3141) 3141
antidotes - therapeutic use (2766) 2766
male (1747) 1747
animals (1553) 1553
female (1277) 1277
toxicology (987) 987
antidotes (969) 969
adult (881) 881
poisoning (674) 674
pharmacology & pharmacy (668) 668
abridged index medicus (648) 648
antidotes - administration & dosage (620) 620
middle aged (599) 599
rats (592) 592
poisoning - drug therapy (563) 563
mice (478) 478
antidote (469) 469
antidotes - pharmacology (461) 461
toxicity (451) 451
poisoning - therapy (408) 408
aged (394) 394
treatment outcome (367) 367
adolescent (343) 343
time factors (332) 332
child (323) 323
overdose (315) 315
care and treatment (311) 311
health aspects (304) 304
charcoal - therapeutic use (279) 279
dose-response relationship, drug (253) 253
child, preschool (249) 249
emergency medicine (248) 248
intoxication (240) 240
administration, oral (234) 234
medicine, general & internal (231) 231
acute disease (221) 221
atropine - therapeutic use (220) 220
drug overdose (219) 219
drugs (217) 217
antidotes - adverse effects (216) 216
acetaminophen - poisoning (207) 207
analysis (199) 199
retrospective studies (191) 191
cyanides - poisoning (188) 188
poisoning - diagnosis (188) 188
management (186) 186
acetylcysteine - therapeutic use (184) 184
organophosphate poisoning (179) 179
therapy (178) 178
drug therapy, combination (177) 177
oncology (174) 174
research (174) 174
rats, wistar (170) 170
pharmacokinetics (169) 169
dosage and administration (166) 166
risk factors (166) 166
suicide, attempted (162) 162
oximes (161) 161
pralidoxime compounds - therapeutic use (161) 161
gastric lavage (160) 160
infant (159) 159
insecticides - poisoning (159) 159
drug overdose - drug therapy (158) 158
efficacy (154) 154
pyrazoles - therapeutic use (153) 153
usage (151) 151
acetylcholinesterase (143) 143
anticoagulants (143) 143
dogs (143) 143
cholinesterase reactivators - therapeutic use (140) 140
lethal dose 50 (140) 140
organophosphorus compounds (140) 140
thiosulfates - therapeutic use (139) 139
pharmacology/toxicology (138) 138
young adult (137) 137
drug therapy (135) 135
infusions, intravenous (132) 132
leucovorin - therapeutic use (132) 132
complications and side effects (131) 131
pediatrics (128) 128
emergency (125) 125
flumazenil - therapeutic use (125) 125
aged, 80 and over (124) 124
anticoagulants - adverse effects (124) 124
acetaminophen (123) 123
dabigatran (123) 123
injections, intravenous (123) 123
antidotes - chemistry (122) 122
chelating agents - therapeutic use (122) 122
renal dialysis (122) 122
disease models, animal (121) 121
hemorrhage - chemically induced (121) 121
oximes - therapeutic use (121) 121
antidotes - pharmacokinetics (119) 119
biochemistry & molecular biology (119) 119
nursing (119) 119
prospective studies (119) 119
biomedicine (118) 118
chemical warfare agents - poisoning (118) 118
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
UofT at Mississauga - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Pharmacy (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3861) 3861
German (200) 200
Russian (191) 191
French (86) 86
Spanish (50) 50
Japanese (31) 31
Chinese (30) 30
Polish (25) 25
Danish (19) 19
Swedish (18) 18
Czech (14) 14
Hungarian (14) 14
Dutch (12) 12
Italian (12) 12
Bulgarian (11) 11
Finnish (10) 10
Serbian (9) 9
Hebrew (5) 5
Norwegian (5) 5
Romanian (5) 5
Croatian (4) 4
Portuguese (2) 2
Turkish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Judeo-Arabic (1) 1
Korean (1) 1
Latin (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2413 - 2424
Journal Article
Circulation, ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
BACKGROUND—Patients experiencing major bleeding while taking vitamin K antagonists require rapid vitamin K antagonist reversal. We performed a prospective... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT REVERSAL | CLINICAL-TRIAL | RECOMBINANT FACTOR-VIII | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | WARFARIN | TRANSFUSION | HEMOPHILIA-A | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 1, pp. 82 - 90
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2015, Volume 198, pp. 62 - 70
Triglyceride micro-emulsions such as Intralipid® have been used to reverse cardiac toxicity induced by a number of drugs but reservations about their... 
Local anesthetic | Biodetoxification | Lipid emulsion | Bupivacaine | Triglyceride | Antidote | ISOLATED RAT-HEART | MYOCARDIAL-FUNCTION | BUPIVACAINE TOXICITY | CHEMISTRY, MULTIDISCIPLINARY | INTRAVENOUS LIPID EMULSION | RECOVERY | RESCUE | SINK | LOCAL-ANESTHETICS | I-NA | PHARMACOLOGY & PHARMACY | CLOMIPRAMINE TOXICITY | Emulsions - therapeutic use | Cardiotoxins - toxicity | Bupivacaine - pharmacokinetics | Cardiotoxicity - physiopathology | Muscle, Skeletal - metabolism | Emulsions - pharmacology | Soybean Oil - pharmacology | Cardiotonic Agents - therapeutic use | Emulsions - administration & dosage | Cardiotoxicity - drug therapy | Myocardium - metabolism | Soybean Oil - administration & dosage | Triglycerides - therapeutic use | Triglycerides - pharmacology | Phospholipids - therapeutic use | Cardiotoxins - pharmacokinetics | Phospholipids - administration & dosage | Bupivacaine - toxicity | Cardiac Output - drug effects | Liver - metabolism | Rats | Soybean Oil - therapeutic use | Cardiotonic Agents - pharmacology | Phospholipids - pharmacology | Triglycerides - administration & dosage | Animals | Cardiotonic Agents - administration & dosage | Cardiotoxicity - metabolism | Models, Biological | Analysis | Triglycerides | Index Medicus | triglyceride | local anesthetic | bupivacaine | antidote | biodetoxification | pharmacotoxicity
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 11/2018, Volume 34, Issue 11, pp. 1371 - 1392
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1113 - 1126
Summary Non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly used in the prevention and treatment of venous thromboembolism and in the... 
Review Article | Bleeding management | Bleeding profiles | Reversal agent | Non-vitamin K oral anticoagulant | Real-world data | DABIGATRAN ANTICOAGULATION | STROKE PREVENTION | HEMOSTATIC AGENTS | real-world data | reversal agent | RANDOMIZED EVALUATION | bleeding management | non-vitamin K oral anticoagulant | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | PROTHROMBIN COMPLEX CONCENTRATE | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | ACUTE VENOUS THROMBOEMBOLISM | ELDERLY-PATIENTS | Perioperative Care | Recombinant Proteins - therapeutic use | Meta-Analysis as Topic | Postoperative Hemorrhage - prevention & control | Humans | Clinical Protocols | Warfarin - adverse effects | Postoperative Hemorrhage - chemically induced | Vulnerable Populations | Antithrombins - pharmacokinetics | Thrombophilia - etiology | Neoplasms - complications | Clinical Trials, Phase III as Topic | Blood Transfusion | Drug Design | Retrospective Studies | Thrombophilia - drug therapy | Antidotes - chemistry | Risk Assessment | Hemorrhage - therapy | Antithrombins - therapeutic use | Atrial Fibrillation - complications | Factor Xa Inhibitors - pharmacokinetics | Randomized Controlled Trials as Topic | Factor Xa Inhibitors - therapeutic use | Intracranial Hemorrhages - therapy | Hemostatic Techniques | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Hemorrhages - chemically induced | Blood Coagulation Factors - therapeutic use | Kidney Failure, Chronic - complications | Aged | Disease Management | Hemorrhage - chemically induced | Antidotes - therapeutic use | Renal Dialysis
Journal Article